BRPI0922964A2 - "métodos, dispostivos e kits para detecção de ancilostomídeo, bem como polipeptídeo coproasp5 e anticorpo purificado de se liga ao mesmo" - Google Patents

"métodos, dispostivos e kits para detecção de ancilostomídeo, bem como polipeptídeo coproasp5 e anticorpo purificado de se liga ao mesmo"

Info

Publication number
BRPI0922964A2
BRPI0922964A2 BRPI0922964A BRPI0922964A BRPI0922964A2 BR PI0922964 A2 BRPI0922964 A2 BR PI0922964A2 BR PI0922964 A BRPI0922964 A BR PI0922964A BR PI0922964 A BRPI0922964 A BR PI0922964A BR PI0922964 A2 BRPI0922964 A2 BR PI0922964A2
Authority
BR
Brazil
Prior art keywords
coproasp5
kits
polypeptide
bind
methods
Prior art date
Application number
BRPI0922964A
Other languages
English (en)
Inventor
David Allen Elsemore
Jinming Geng
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of BRPI0922964A2 publication Critical patent/BRPI0922964A2/pt
Publication of BRPI0922964B1 publication Critical patent/BRPI0922964B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
BRPI0922964-7A 2008-12-12 2009-05-18 Métodos para detectar a presença ou a ausência de um ou mais antígenos de ancilostomídeo em uma amostra, polipeptídeo, anticorpo purificado,dispositivo, kit e imunocomplexo BRPI0922964B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12225408P 2008-12-12 2008-12-12
US61/122,254 2008-12-12
PCT/US2009/044367 WO2010068310A1 (en) 2008-12-12 2009-05-18 Compositions, devices, kits and methods for detecting hookworm

Publications (2)

Publication Number Publication Date
BRPI0922964A2 true BRPI0922964A2 (pt) 2016-07-12
BRPI0922964B1 BRPI0922964B1 (pt) 2021-07-13

Family

ID=42243012

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922964-7A BRPI0922964B1 (pt) 2008-12-12 2009-05-18 Métodos para detectar a presença ou a ausência de um ou mais antígenos de ancilostomídeo em uma amostra, polipeptídeo, anticorpo purificado,dispositivo, kit e imunocomplexo

Country Status (3)

Country Link
KR (1) KR101507638B1 (pt)
BR (1) BRPI0922964B1 (pt)
WO (1) WO2010068310A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019355429B2 (en) 2018-10-02 2023-07-20 Idexx Laboratories, Inc. Methods, devices, kits and compositions for detecting tapeworm

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303752B2 (en) * 2001-10-17 2007-12-04 The George Washington University Hookworm vaccine
US7781170B2 (en) * 2003-04-25 2010-08-24 Idexx Laboratories, Inc. Detection of analytes in fecal samples

Also Published As

Publication number Publication date
WO2010068310A1 (en) 2010-06-17
KR20110096573A (ko) 2011-08-30
BRPI0922964B1 (pt) 2021-07-13
KR101507638B1 (ko) 2015-04-01

Similar Documents

Publication Publication Date Title
CY2022036I2 (el) Πρωτεϊνες δεσμευομενες με αντιγονο ικανες να δεσμευονται με θυμικη στρωματικη λεμφοποιητινη
CY2017021I1 (el) Υψηλης συναφειας ανθρωπινα αντισωματα προς pcsk9
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0916973A2 (pt) anticorpos para ccr2
LTPA2018002I1 (lt) Didelio afiniškumo žmogaus antikūnai prieš žmogaus IK-4 receptorius
IL255300A0 (en) Antibodies to matrix metalloproteinase 9
EP3689911C0 (en) CLAUDIN 6 (CLDN6) SPECIFIC ANTIBODIES
BRPI0812206A2 (pt) Métodos para melhorar o desempenho de proteínas
BRPI0920961A2 (pt) mecanismo de procura estrutura de emprego
BRPI0911590A2 (pt) método de aumento de recuperação de hidrocarbonos
EP2118778A4 (en) PROCESSING SEARCH GROUPING
BRPI0812603A2 (pt) "método para prevenir a redução de pontes dissulfeto"
HRP20190047T1 (hr) Protutijela koja se vežu na csf1r
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
BRPI0819050A2 (pt) Método para desidroaromatizar metano
BRPI0908303A2 (pt) Recuperação de ácidos orgânicos
BRPI0817775A2 (pt) Métodos de tratar distúrbios urogenitais-neurológicos usando toxinas clostridiais modificadas
BRPI0817547A2 (pt) Método para realizar pirólise
BRPI0810929A2 (pt) "método para proteger"
BRPI0814804A2 (pt) Método de intensificar recuperação de óleo
BR112013006403A2 (pt) purificação de anticorpos usando cromatografia de leito móvel simulado
DK2732260T3 (da) Prøveopsamlingskit
BRPI0919547A2 (pt) anticorpos que se ligam a il-12 e métodos de purificação do mesmo
EP2548556A4 (en) METHOD FOR IMPROVING THE SOLUBILITY OF ANY COOLING PREVENTION AGENT
NO20085365A (no) Invertert indeks for kontekstuell søk

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.